The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

The case of avian influenza A (H5) confirmed by the Centers for Disease Control and Prevention in Missouri, USA, on Sept 6, 2024,1 has reignited concerns about the risk of human contagion and the need ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

A strain of influenza appears to have disappeared from the planet since COVID. As a result, U.S. flu vaccines have been ...

Shares of Novavax NVAX lost nearly 20% on Wednesday after the company announced that the FDA has placed a clinical hold on ...

The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 trial of a combination shot for COVID-19 and influenza.

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

The most important thing to know is that the COVID vaccine is safe and effective, says Dr. Watkins. With that said, side effects from the COVID vaccine are rare, says Dr. Cennimo, and they usually ...

There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna ... time that ...

GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks ...